Thoughts on B-vitamins and dementia
- PMID: 16917152
- PMCID: PMC3428233
- DOI: 10.3233/jad-2006-9409
Thoughts on B-vitamins and dementia
Abstract
The B-vitamins, including vitamins B12, B6, B1, B2, niacin (B3) and folate (B9), have been implicated as protective risk factors against cognitive decline and Alzheimer's disease. This commentary reviews the evidence to support protective relations of these vitamins, including consideration of known vitamin deficiency syndromes, theories of underlying biologic mechanisms, and the epidemiologic evidence. We also comment on the potential benefits and harms of vitamin supplementation as well as make recommendations for the direction of future studies.
References
-
- Goetz CG, Pappert EJ. Textbook of Clinical Neurology. Philladelphia: W.B. Saunders; 1999.
-
- Savage DG, Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. [Review] [114 refs] Baillieres Clinical Haematology. 1995;8(3):657–678. - PubMed
-
- Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency I: Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol. 1990;34:90–98. - PubMed
-
- Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin 15. Blood. 1998;92(4):1191–1198. - PubMed
-
- Morris MS, Jacques PF, Rosenberg IH, Selhub J. Elevated serum methylmalonic acid concentrations are common among elderly Americans 6. J Nutr. 2002;132(9):2799–2803. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
